Compounded Tirzepatide may be prescribed by a licensed medical provider as part of a medically supervised metabolic or weight management program. This medication is prepared by a licensed compounding pharmacy based on individualized patient needs and provider direction.
Tirzepatide is a GLP-1 and GIP receptor agonist that acts on hormonal pathways involved in appetite regulation and glucose metabolism. When prescribed, compounded Tirzepatide may help support appetite control and glycemic regulation as part of a comprehensive, provider-guided care plan.
Treatment suitability is determined by a licensed provider following a medical evaluation. Individual results may vary, and compounded medications are not reviewed or approved by the FDA.

